ArticlePolymers2025
Application of a New Carbon Black Filler in SBR Composites.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The microstructure and properties of a new type of carbon black produced by a domestic company through a new process were systematically characterized by scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), Raman spectroscopy, and X-ray diffraction (XRD). The vulcanization properties, mechanical properties, and electrical conductivity of the new carbon black with different filler amounts were investigated in styrene butadiene rubber (SBR), using the traditional reinforcing filler N660 carbon black as a control. The experimental results demonstrate that the new carbon black exhibits a stratified structure with a specific surface area of 345.96 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.